144 related articles for article (PubMed ID: 15279030)
1. Reassessment of the carcinogenicity of polychlorinated biphenyls (PCBs).
Smith MA
J Toxicol Environ Health; 1997 Apr; 50(6):567-79. PubMed ID: 15279030
[TBL] [Abstract][Full Text] [Related]
2. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment.
Safe SH
Crit Rev Toxicol; 1994; 24(2):87-149. PubMed ID: 8037844
[TBL] [Abstract][Full Text] [Related]
3. Development of an oral cancer slope factor for Aroclor 1268.
Warren DA; Kerger BD; Britt JK; James RC
Regul Toxicol Pharmacol; 2004 Aug; 40(1):42-53. PubMed ID: 15265605
[TBL] [Abstract][Full Text] [Related]
4. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
5. Development of a neurotoxic equivalence scheme of relative potency for assessing the risk of PCB mixtures.
Simon T; Britt JK; James RC
Regul Toxicol Pharmacol; 2007 Jul; 48(2):148-70. PubMed ID: 17475378
[TBL] [Abstract][Full Text] [Related]
6. Potential human cancer risks from exposure to PCBs: a tale of two evaluations.
Golden R; Doull J; Waddell W; Mandel J
Crit Rev Toxicol; 2003; 33(5):543-80. PubMed ID: 14594106
[TBL] [Abstract][Full Text] [Related]
7. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment.
Giesy JP; Kannan K; Blankenship AL; Jones PD; Hilscherova K
Cent Eur J Public Health; 2000 Jul; 8 Suppl():43-5. PubMed ID: 10943457
[TBL] [Abstract][Full Text] [Related]
8. Toxicity equivalency factors for PCBs?
Barnes D; Alford-Stevens A; Birnbaum L; Kutz FW; Wood W; Patton D
Qual Assur; 1991 Oct; 1(1):70-81. PubMed ID: 1669971
[TBL] [Abstract][Full Text] [Related]
9. Understanding population and individual risk assessment: the case of polychlorinated biphenyls.
Shields PG
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):830-9. PubMed ID: 16702358
[TBL] [Abstract][Full Text] [Related]
10. Weight of evidence evaluation of potential human cancer risks from exposure to polychlorinated biphenyls: an update based on studies published since 2003.
Golden R; Kimbrough R
Crit Rev Toxicol; 2009; 39(4):299-331. PubMed ID: 19514916
[TBL] [Abstract][Full Text] [Related]
11. A case study of cancer data set combinations for PCBs.
Vater ST; Velazquez SF; Cogliano VJ
Regul Toxicol Pharmacol; 1995 Aug; 22(1):2-10. PubMed ID: 7494898
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenicity of "non-dioxinlike" polychlorinated biphenyls.
Knerr S; Schrenk D
Crit Rev Toxicol; 2006 Oct; 36(9):663-94. PubMed ID: 17050081
[TBL] [Abstract][Full Text] [Related]
13. Development of TEFs for PCB congeners by using an alternative biomarker--thyroid hormone levels.
Yang JM; Salmon AG; Marty MA
Regul Toxicol Pharmacol; 2010 Mar; 56(2):225-36. PubMed ID: 20043972
[TBL] [Abstract][Full Text] [Related]
14. Modeling and assaying dioxin-like biological effects for both dioxin-like and certain non-dioxin-like compounds.
Wilkes JG; Hass BS; Buzatu DA; Pence LM; Archer JC; Beger RD; Schnackenberg LK; Halbert MK; Jennings L; Kodell RL
Toxicol Sci; 2008 Mar; 102(1):187-95. PubMed ID: 18065775
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of various exposure metrics in defining dose-response relationships for mink (Mustela vison) exposed to polychlorinated biphenyls.
Fuchsman PC; Barber TR; Bock MJ
Arch Environ Contam Toxicol; 2008 Jan; 54(1):130-44. PubMed ID: 17943339
[TBL] [Abstract][Full Text] [Related]
16. A comparison of liver tumor diagnoses from seven PCB studies in rats.
Moore JA; Hardisty JF; Banas DA; Smith MA
Regul Toxicol Pharmacol; 1994 Dec; 20(3 Pt 1):362-70. PubMed ID: 7724839
[TBL] [Abstract][Full Text] [Related]
17. Integrating data gap filling techniques: A case study predicting TEFs for neurotoxicity TEQs to facilitate the hazard assessment of polychlorinated biphenyls.
Pradeep P; Carlson LM; Judson R; Lehmann GM; Patlewicz G
Regul Toxicol Pharmacol; 2019 Feb; 101():12-23. PubMed ID: 30359698
[TBL] [Abstract][Full Text] [Related]
18. Selection of non-dioxin-like PCBs for in vitro testing on the basis of environmental abundance and molecular structure.
Stenberg M; Andersson PL
Chemosphere; 2008 May; 71(10):1909-15. PubMed ID: 18281077
[TBL] [Abstract][Full Text] [Related]
19. Effects of non-dioxin-like polychlorinated biphenyl congeners (PCB 101, PCB 153 and PCB 180) alone or mixed on J774A.1 macrophage cell line: modification of apoptotic pathway.
Ferrante MC; Mattace Raso G; Esposito E; Bianco G; Iacono A; Clausi MT; Amero P; Santoro A; Simeoli R; Autore G; Meli R
Toxicol Lett; 2011 Apr; 202(1):61-8. PubMed ID: 21291966
[TBL] [Abstract][Full Text] [Related]
20. Estimation of the health risks associated with polychlorinated biphenyl (PCB) concentrations found onboard older U.S. Navy vessels.
Still KR; Arfsten DP; Jederberg WW; Kane LV; Larcom BJ
Appl Occup Environ Hyg; 2003 Oct; 18(10):737-58. PubMed ID: 12959885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
